We demonstrated that chronic treatment with the antidepressant duloxetine improved the cognitive dysfunction in EDS and the decreased expression of BDNF in the mPFC of previously stressed adult mice. The gene discussed is BDNF; the disease is Ehlers-Danlos syndrome.